| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 09/08/2004 | EP1453809A1 Process for the preparation of 4-methyl-7-aminoquinolones |
| 09/08/2004 | EP1453801A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 09/08/2004 | EP1453789A2 N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/08/2004 | EP1453544A2 Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors |
| 09/08/2004 | EP1453512A1 Acetylene derivatives having mglur 5 antagonistic activity |
| 09/08/2004 | EP1345603A4 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 09/08/2004 | EP1165505B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 09/08/2004 | EP0785782B1 Use of disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid-like activity |
| 09/08/2004 | CN1527827A Therapeutic heterocyclic compounds |
| 09/08/2004 | CN1527709A Therapeutic combinations for cardiovascular and inflammatory indications |
| 09/08/2004 | CN1165532C Substituted 3-cyanoquinolines as protein tyrosine kinase inhibitors |
| 09/08/2004 | CN1165531C Alpha-methylbenzyl-containing thioure a inhibitors of herpes viruses containing phenylenedimine group |
| 09/07/2004 | US6787558 Neuropeptide y receptor antagonists, for treating arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders and obesity |
| 09/07/2004 | US6787557 2,3-dimethyl-6-t-butyl-8-fluoro-4-hydroxyquinoline or ester derivatives; plant fungicides; Pyricularia |
| 09/07/2004 | US6787534 Sulfonamide-containing heterocyclic compounds |
| 09/07/2004 | US6787522 Antibacterial agents |
| 09/07/2004 | CA2105709C Substituted cyclohexane derivatives, processes for their preparation and the use of the compounds for treating diseases |
| 09/02/2004 | WO2004074255A2 Method for producing an optically active tetrahydroquinoline |
| 09/02/2004 | WO2004074254A1 Fluorescent lanthanide complex |
| 09/02/2004 | WO2004074218A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/02/2004 | WO2004073709A1 Antimicrobial agents |
| 09/02/2004 | WO2004073628A2 Novel compounds |
| 09/02/2004 | WO2004073606A2 Sulfonamide derivatives as ppar modulators |
| 09/02/2004 | WO2004035569A3 Novel compounds with antibacterial activity |
| 09/02/2004 | WO2004014851A3 Tyrosine kinase inhibitors |
| 09/02/2004 | US20040171881 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/02/2004 | US20040171835 Tetrahydroquinoline derivative compound and drug containing the compound as active ingredient |
| 09/02/2004 | US20040171653 HIV, AIDS; such as 2-[[(dimethylamino)acetyl]amino]-N-[3-[[[(2-hydroxy-1,1-dimethylethyl)amino]sulfonyl](3-methylbutyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-3,3-dimethylbutanamide |
| 09/02/2004 | US20040171641 Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP) |
| 09/02/2004 | US20040171638 Chemokine receptor binding heterocyclic compounds |
| 09/02/2004 | US20040171621 Novel crystalline forms of gatifloxacin and processes for preparation |
| 09/02/2004 | US20040171543 Matrix metalloproteinase inhibitors and methods for identification of lead compounds |
| 09/02/2004 | CA2515939A1 Novel compounds |
| 09/02/2004 | CA2514862A1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/02/2004 | CA2512883A1 Sulfonamide derivatives as ppar modulators |
| 09/01/2004 | EP1451167A1 Phenylalkynes |
| 09/01/2004 | EP1451159A1 Compositions derived from quinoline and quinoxaline, preparation and use thereof |
| 09/01/2004 | EP1451158A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties |
| 09/01/2004 | EP1451157A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties |
| 09/01/2004 | EP1451156A1 4-aminoquinoline compounds |
| 09/01/2004 | EP1451148A2 2,w-diaminocarboxylic acid compounds |
| 09/01/2004 | EP1450818A2 A method for treating inflammatory bowel disease |
| 09/01/2004 | EP1450806A1 Use of sulfonamide derivatives in the treatment of obesity or for the reduction of food intake |
| 09/01/2004 | EP1450803A1 New uses for anti-malarial therapeutic agents |
| 09/01/2004 | EP1450801A2 2-aminoquinoline compounds |
| 09/01/2004 | EP1228024B1 Novel hydronaphthalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 09/01/2004 | EP1140851B1 4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents |
| 09/01/2004 | EP1048655B1 1,2-dihydro-2-oxoquinoline derivatives |
| 09/01/2004 | EP0837850B1 4-acylamino(halogeno) alkyl-quinoline derivatives, their preparation and their use as melatonin agonists |
| 09/01/2004 | CN1525957A Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 08/31/2004 | US6784210 Decyclization of oxabenzonorbornadienes or azabicyclic compounds in the presence of catalysts to form naphthalenes, such as 2-methoxy-1,2-dihydronaphthalen-1-ol, used as analgesics, anticarcinogens or viricides; catalysis |
| 08/31/2004 | US6784193 Mutilin derivatives and their use as antibacterials |
| 08/31/2004 | US6784189 Potassium channel inhibitors and method |
| 08/31/2004 | US6784181 Ligands for the delta receptor |
| 08/26/2004 | WO2004072087A2 Metal complexes as light-absorbing compounds in the information layer of optical data carriers |
| 08/26/2004 | WO2004072045A1 Substituted quinoline-4-carboxylic hydrazides as nk-2/nk-3 receptor ligands |
| 08/26/2004 | WO2004072044A2 Urea and thiourea derivatives |
| 08/26/2004 | WO2004072043A1 Benzyl urea and thiourea derivatives useful as androgen antagonists |
| 08/26/2004 | WO2004072042A2 Quinoline derivative and their use for modulation of lxr activity |
| 08/26/2004 | WO2004072041A1 Tetrahydroquinolines as agonists of liver- x receptors |
| 08/26/2004 | WO2004072040A1 Crystalline forms of pitavastatin calcium |
| 08/26/2004 | WO2004072027A2 Chemical derivatives binding very specifically with g-quadruplex dna structures and use thereof as a specific anti-cancer agent |
| 08/26/2004 | WO2004058164A3 Asthma and allergic inflammation modulators |
| 08/26/2004 | WO2004043355A3 Alpha, alpha-disubstituted benzylglycine derivatives as hiv protease inhibitors |
| 08/26/2004 | WO2004013094A3 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 08/26/2004 | US20040167332 Boronic ester and acid compounds, synthesis and uses |
| 08/26/2004 | US20040167162 therapy for infection of adenovirus, rhinovirus ; using an (amino or hydroxy)quinoline compound |
| 08/26/2004 | US20040167160 Skin disorders; controlling cell differentiation; antidiabetic agents; cardiovascular disorders; anticancer agents; central nervous system disorders |
| 08/26/2004 | US20040167151 Flavone acetic acid analogs and methods of use thereof |
| 08/26/2004 | US20040167135 Dihydropyrimidines |
| 08/26/2004 | US20040167126 Such as (2RS,3R)-3-amino-4-cyclohexyl-2-hydroxy-N-phenoxybutanamide; methionine aminopeptidase type 2 inhibitors |
| 08/26/2004 | US20040167116 Viricides |
| 08/26/2004 | CA2785954A1 Crystalline forms of pitavastatin calcium |
| 08/26/2004 | CA2515589A1 Urea and thiourea derivatives |
| 08/26/2004 | CA2514244A1 Benzyl urea and thiourea derivatives useful as androgen antagonists |
| 08/26/2004 | CA2514222A1 Substituted quinoline-4-carboxylic hydrazides as nk-2/nk-3 receptor ligands |
| 08/26/2004 | CA2514105A1 Chemical derivatives binding very specifically with g-quadruplex dna structures and use thereof as a specific anti-cancer agent |
| 08/26/2004 | CA2513837A1 Crystalline forms of pitavastatin calcium |
| 08/25/2004 | EP1449834A2 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas |
| 08/25/2004 | EP1448531A1 3-cyanoquinolines as inhibitors of egf-r and her2 kinases |
| 08/25/2004 | EP1448529A1 Sulfone derivatives and their use in the treatment of autoimmune diseases and allergies |
| 08/25/2004 | EP1448514A1 Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives |
| 08/25/2004 | EP1448218A2 Beta-secretase inhibitors and methods of use |
| 08/25/2004 | EP1150977B1 Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists |
| 08/25/2004 | CN1524077A Therapeutic chroman compounds |
| 08/25/2004 | CN1523989A Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/25/2004 | CN1522701A Epoxy-steroidal aldosterone antagonist and angiotensin ii antagonist combination therapy |
| 08/25/2004 | CN1163486C Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 08/24/2004 | US6780996 Process for the preparation of 7-substituted-3 quinolinecarbonitriles |
| 08/24/2004 | US6780890 Contacting s-adenosylhomocysteine (sah with a luxs protein whereby s- adenosylhomocysteine undergoes conversion to autoinducer-2 |
| 08/24/2004 | US6780883 Anticholesterol agents; cardiovascular disorders; antilipemic agents; restenosis; dietetics |
| 08/24/2004 | US6780875 Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists |
| 08/24/2004 | US6780858 Hydroxyamidines and related compounds |
| 08/24/2004 | CA2065051C Improved use of .beta.2 bronchodilator drugs |
| 08/19/2004 | WO2004069826A1 Malonamide derivatives as gamma-secretase inhibitors |
| 08/19/2004 | WO2004069825A1 Synthesis of gatifloxacin |
| 08/19/2004 | WO2004069793A2 Novel 2-substituted cyclic amines as calcium sensing receptor modulators |
| 08/19/2004 | WO2004069792A2 Quinoline-derived amide modulators of vanilloid vr1 receptor |
| 08/19/2004 | WO2004069145A2 Anticancer compounds, process for their preparation and pharmaceutical compositions containing them |
| 08/19/2004 | WO2004062571A3 Substantially pure cilostazol and processes for making same |